Anti-BCL10 aptamer SELEX Service(Cat#: CTApt-1866)
This is an aptamer development services to screening aptamers binds to the BCL10 with an affinity of 1nM~1μM.
Specific Inquiry 
Specifications
| Target Category |
Protein |
| Target |
BCL10 |
| Alternative Names |
BCL10 Immune Signaling Adaptor; CIPER; C-E10; CLAP; ME10; CED-3/ICH-1 Prodomain Homologous E10-Like Regulator; Mammalian CARD-Containing Adapter Molecule E10; CARD-Containing Molecule Enhancing NF-Kappa-B; Caspase-Recruiting Domain-Containing Protein; CARD-Containing Apoptotic Signaling Protein; CARD Containing Molecule Enhancing NF-KB; CARD-Containing Proapoptotic Protein; CARD-Like Apoptotic Protein; B-Cell Lymphoma/Leukemia 10; Cellular Homolog Of VCARMEN; B Cell CLL/Lymphoma 10; Cellular-E10; CCARMEN; CARMEN; HCLAP; BCL10, Immune Signaling Adaptor; B-Cell CLL/Lymphoma 10; Bcl-10; IMD37; BCL10 |
| Gene ID |
8915 |
| UniProt ID |
O95999 |
| Target Overview |
This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. |
| Chemical Modification |
N/A |
| Type |
DNA |
| Length |
20-80 nt |
| Affinity (Kd) |
1nM~1μM |
| Binding Conditions/Buffer |
PBS; buffer system with Serum; other |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
